Insulin degludec in Japanese patients with type 1 diabetes mellitus: A randomized controlled trial
INTRODUCTION: Insulin degludec is an ultra‐long‐acting insulin with a flat time‐action profile and duration of action >42 h. Data from several studies have shown insulin degludec to have a favorable therapeutic profile in type 1 and type 2 diabetes. MATERIALS AND METHODS: This was a 6‐week, paral...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley-Blackwell
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019289/ https://www.ncbi.nlm.nih.gov/pubmed/24843632 http://dx.doi.org/10.1111/j.2040-1124.2012.00240.x |